A Retrospective Cohort Study to Predict Early Recurrence in Colorectal Liver Metastases Using a Nomogram Model
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.70195 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Deng Zhao Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Department, Yueqing People's Hospital, Wenzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Nomograms, Liver Neoplasms, Colorectal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
The incidence of colorectal liver metastases (CRLM) is rising, with only a subset of patients eligible for intent‐to‐cure treatment. Among these, up to 67% experience recurrence, with a worse prognosis for those with early recurrence. Reliable predictive models for early recurrence are needed.
Objective
To identify predictive factors for early recurrence in CRLM patients, construct a nomogram, and compare its predictive performance against a clinical risk score (CRS) model.
Methods
This study analyzed 240 CRLM patients who underwent intent‐to‐cure treatment at our center between January 2019 and August 2024. After applying inclusion and exclusion criteria, 198 patients were included. CRSs were calculated, and independent predictors of early recurrence were identified using univariate and multivariate Cox regression analyses. The nomogram model was evaluated using receiver operating characteristic (ROC) analysis, calibration, and decision curve analysis.
Results
Significant predictors of early recurrence included primary tumor location ( p = 0.0014), primary tumor T stage ( p = 0.0015), M stage ( p = 0.0298), number of liver metastases ( p = 0.003), metastatic tumor size ( p = 0.0041), efficacy of neoadjuvant chemotherapy ( p = 0.0043), and RAS mutation ( p < 0.001). Independent predictors were primary tumor location, RAS mutation, number of metastases, and metastatic tumor size ( p = 0.0047, p = 0.0116, p = 0.0423, and p < 0.0001, respectively). The nomogram model significantly outperformed the CRS model (AUC 0.790 vs. 0.604, p < 0.0001) and demonstrated superior clinical utility in decision curve analysis.
Conclusions
Primary tumor location, RAS mutation, and the extent of liver metastases are independent predictors of early recurrence in CRLM patients post‐treatment. A nomogram integrating these factors demonstrated strong predictive performance, making it a practical tool for clinicians.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepatobiliary Department, Yueqing People's Hospital, Wenzhou, Zhejiang, People's Republic of China.
- Department of Hepato-Pancreato-Biliary Surgery, Ningbo Medical Center Lihuili Hospital, Health Science Center, Ningbo University, Ningbo, Zhejiang, People's Republic of China.
- Health Science Center, Ningbo University, Ningbo, Zhejiang, People's Republic of China.
ORCID-Profile: Joseph Mugaanyi
Zitieren
APA
Wu, D. Z., Zhang, Z., & Mugaanyi, J. (2025). A Retrospective Cohort Study to Predict Early Recurrence in Colorectal Liver Metastases Using a Nomogram Model. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70195
Vancouver
Wu DZ, Zhang Z, Mugaanyi J. A Retrospective Cohort Study to Predict Early Recurrence in Colorectal Liver Metastases Using a Nomogram Model. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70195
BibTeX
@article{Wu2025,
author = {Wu, Deng Zhao and Zhang, Zan and Mugaanyi, Joseph},
title = {A Retrospective Cohort Study to Predict Early Recurrence in Colorectal Liver Metastases Using a Nomogram Model},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.70195}
}
EUVIMED